The Dana-Farber Cancer Institute, an affiliate of the Harvard Medical School, will retract or correct dozens of papers by four top cancer researchers following the results of a data falsification investigation.
Six papers will be retracted entirely, and 31 will have corrections issued, per the results of an investigation started after allegations of data manipulation against the institute’s president and CEO, Laurie H. Glimcher, and three other researchers.
Fifty-seven papers are being reviewed in the investigation into Glimcher, Executive Vice President and Chief Operating Officer William C. Hahn, Senior Vice President for Experimental Medicine Irene M. Ghobrial, and Harvard Medical School professor Kenneth C. Anderson.
The corrections come after former university President Claudine Gay was caught in a plagiarism scandal that led to her ouster. In addition, Harvard Business School professor Francesca Gino was Read more…